Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC16H16ClN7O |
InChIKeyZDXWENNHTOBFEW-UHFFFAOYSA-N |
CAS Registry904576-65-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cryptosporidiosis | Preclinical | US | 08 Jan 2018 |